Abstract
Obesity has long been associated with endometrial cancer. However, there is a paucity of studies addressing the impact of morbid obesity in type II endometrial cancer on oncologic and surgical outcomes. In this study, the author retrospectively compared morbid to non-morbid obese in clinico-epidemiologic, surgical, and oncologic outcomes. Both groups were comparable as regards all clinico-epidemiologic parameters. Vaginal involvement, survival, and recurrence were also comparable between the 2 groups. Para-aortic adenopathy and treatment with preoperative therapy were the only significant predictors of DFS. Surgery is feasible with equivalent complications and oncologic outcomes in morbidly obese patients with type II endometrial cancer.
Similar content being viewed by others
References
Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335(7630):1134. https://doi.org/10.1136/bmj.39367.495995.AE
Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579–591. https://doi.org/10.1038/nrc1408
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (London, England) 371(9612):569–578. https://doi.org/10.1016/S0140-6736(08)60269-X
Fambrini M, Pieralli A, Bitossi U et al (2012) Mini-laparotomy versus vaginal surgery for class II-III obese patients with early-stage endometrial cancer. Anticancer Res 32(2):707–712
Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I (2007) Treatment modalities in endometrial cancer. Curr Opin Oncol 19(5):479–485. https://doi.org/10.1097/CCO.0b013e32827853c0
Santi A, Kuhn A, Gyr T et al (2010) Laparoscopy or laparotomy? A comparison of 240 patients with early-stage endometrial cancer. Surg Endosc 24(4):939–943. https://doi.org/10.1007/s00464-009-0565-5
Hecht JL, Mutter GL (2006) Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol Off J Am Soc Clin Oncol 24(29):4783–4791. https://doi.org/10.1200/JCO.2006.06.7173
Prat J, Gallardo A, Cuatrecasas M, Catasús L (2007) Endometrial carcinoma: pathology and genetics. Pathology 39(1):72–87. https://doi.org/10.1080/00313020601136153
Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15(1):10–17. https://doi.org/10.1016/0090-8258(83)90111-7
Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R (1982) Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6(2):93–108. https://doi.org/10.1097/00000478-198203000-00002
Fader AN, Nagel C, Axtell AE et al (2009) Stage II uterine papillary serous carcinoma: carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes. Gynecol Oncol 112(3):558–562. https://doi.org/10.1016/j.ygyno.2008.11.016
Fader AN, Starks D, Gehrig PA et al (2009) An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC). Gynecol Oncol 115(2):244–248. https://doi.org/10.1016/j.ygyno.2009.07.030
Zhang Y, Liu Z, Yu X et al (2010) The association between metabolic abnormality and endometrial cancer: a large case-control study in China. Gynecol Oncol 117(1):41–46. https://doi.org/10.1016/j.ygyno.2009.12.029
Setiawan VW, Yang HP, Pike MC et al (2013) Type I and II endometrial cancers: have they different risk factors? J Clin Oncol Off J Am Soc Clin Oncol 31(20):2607–2618. https://doi.org/10.1200/JCO.2012.48.2596
McCullough ML, Patel AV, Patel R et al (2008) Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol biomarkers Prev a Publ Am Assoc Cancer Res cosponsored by Am Soc Prev Oncol 17(1):73–79. https://doi.org/10.1158/1055-9965.EPI-07-2567
Bjørge T, Engeland A, Tretli S, Weiderpass E (2007) Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J cancer 120(2):378–383. https://doi.org/10.1002/ijc.22260
Afshin A, Forouzanfar MH, Reitsma MB et al (2017) Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 377(1):13–27. https://doi.org/10.1056/NEJMoa1614362
Pavelka JC, Ben-Shachar I, Fowler JM et al (2004) Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients. Gynecol Oncol 95(3):588–592. https://doi.org/10.1016/j.ygyno.2004.07.047
Giugale LE, Di Santo N, Smolkin ME, Havrilesky LJ, Modesitt SC (2012) Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia. Gynecol Oncol 127(2):326–331. https://doi.org/10.1016/j.ygyno.2012.08.014
Santoso JT, Barton G, Riedley-Malone S, Wan JY (2012) Obesity and perioperative outcomes in endometrial cancer surgery. Arch Gynecol Obstet 285(4):1139–1144. https://doi.org/10.1007/s00404-011-2116-2
Januszek SM, Barnas E, Skret-Magierlo J et al (2019) Obesity as a risk factor of in-hospital outcomes in patients with endometrial cancer treated with traditional surgical mode. Ginekol Pol 90(10):549–556. https://doi.org/10.5603/GP.2019.0095
Akbayır O, Corbacıoglu Esmer A, Numanoglu C et al (2012) Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer. Arch Gynecol Obstet 286(5):1269–1276. https://doi.org/10.1007/s00404-012-2431-2
Rabischong B, Larraín D, Canis M et al (2011) Long-term follow-up after laparoscopic management of endometrial cancer in the obese: a fifteen-year cohort study. J Minim Invasive Gynecol 18(5):589–596. https://doi.org/10.1016/j.jmig.2011.05.015
Erkanli S, Kayaselçuk F, Bagis T, Kuşçu E (2006) Impact of morbid obesity in surgical management of endometrial cancer: surgical morbidity, clinical and pathological aspects. Eur J Gynaecol Oncol 27(4):401–404
Gambacorti-Passerini ZM, López-De la Manzanara Cano C, Pérez Parra C, et al. (2019) Obesity in patients with endometrial cancer: may it affect the surgical outcomes of laparoscopic approach? Obes Surg. 29(10):3285–3290. https://doi.org/10.1007/s11695-019-03986-2
Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N (2005) Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Gynecol Oncol 96(3):651–657. https://doi.org/10.1016/j.ygyno.2004.11.026
Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC, Miller DS (1991) Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 78(1):63–69
Morrow CP, Bundy BN, Kurman RJ et al (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40(1):55–65. https://doi.org/10.1016/0090-8258(91)90086-k
Jeong N-H, Lee J-M, Lee J-K et al (2010) Role of body mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women. Gynecol Oncol 118(1):24–28. https://doi.org/10.1016/j.ygyno.2010.03.001
Modesitt SC, Tian C, Kryscio R et al (2007) Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study. Gynecol Oncol 105(1):59–65. https://doi.org/10.1016/j.ygyno.2006.10.045
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Approval was obtained from Mansoura Faculty of Medicine Institutional Review Board (MFM-IRB) with code number R.20.12.1137.
Consent to Participate
Informed consent was obtained from the patient included in the study.
Consent for Publication
Consent for publication was obtained from the patients included in the study.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gaballa, K., Metwally, I.H., Refky, B. et al. Impact of Morbid Obesity on the Outcomes of Type II Endometrial Cancer: a Cohort Study. Indian J Surg Oncol 13, 453–458 (2022). https://doi.org/10.1007/s13193-022-01503-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-022-01503-z